05.11.2014 Views

koah akut atağında farklı steroid dozlarının solunum fonksiyonları ...

koah akut atağında farklı steroid dozlarının solunum fonksiyonları ...

koah akut atağında farklı steroid dozlarının solunum fonksiyonları ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

54<br />

8. SUMMARY<br />

Aims:<br />

İn this study, effects of 1 mg/kg/day versus 2 mg/kg/day prednisolone on<br />

blood gas analysis respiratory functions, dyspnea score and long-term quality of life<br />

has been compared in patients with acute attack of chronic obstructive pulmonary<br />

disease (COPD).<br />

Material- methotds:<br />

A total of 32 patients presenting with acute severe or very-severe COPD<br />

attack were included. Patients were randomized to receive 1 mg/kg/day (n=16) or 2<br />

mg/kg/day (n=16) prednisolone, in addition to combined short acting β 2 -agonist,<br />

ipratropiumbromide nebulised therapy, theophilline, mucolityc, antibiotic and<br />

oxygen treatment. The dosage of <strong>steroid</strong> has been decreased gradually and weaned of<br />

at day 10.<br />

Blood was drawn at the baseline, at 12-, 24-, 36-, 48-hour, at 3-, 5- and at 10-<br />

day of the treatment for blood gas analysis. Baseline, 3- and 10-day and 3-month<br />

respiratory functions were performed. Baseline, 3- and 10-day Borg dyspnea scores<br />

were recorded. Baseline and 3- month SGRQ scores were recorded. A 6-minute walk<br />

test was performed at discharge and at 3-month.<br />

Results:<br />

İn the both groups, an increase in PaO 2 and pH, and a decrease in PaCO 2 was<br />

observed as the duration of the treatment increased. However, no statistical<br />

differences were found between the two-groups with regard to any parameters of the<br />

blood gas analysis in the blood drawn at the same time frame (all p>0.05)<br />

At the end of the treatment, Borg dyspnea score were decreased in the both<br />

groups. However, no significant difference was observed between the groups<br />

(p>0.05).<br />

When we compared the 3-month SGRQ with the baseline questionnaire, no<br />

statistically significant differences were observed with respect to symptom, activity,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!